Woodline Partners’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Buy |
146,916
+543
| +0.4% | +$11.8K | 0.02% | 642 |
|
|
2025
Q1 | $2.71M | Buy |
146,373
+576
| +0.4% | +$10.7K | 0.02% | 620 |
|
|
2024
Q4 | $3.88M | Buy |
145,797
+24,853
| +21% | +$662K | 0.03% | 534 |
|
|
2024
Q3 | $2.84M | Buy |
120,944
+20,944
| +21% | +$492K | 0.02% | 442 |
|
|
2024
Q2 | $1.86M | Hold |
100,000
| – | – | 0.02% | 420 |
|
|
2024
Q1 | $1.79M | Buy |
+100,000
| New | +$1.79M | 0.02% | 427 |
|